<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01113866</url>
  </required_header>
  <id_info>
    <org_study_id>CV-1997-2002_A0013-29943</org_study_id>
    <nct_id>NCT01113866</nct_id>
  </id_info>
  <brief_title>Biomarkers for Prognosis of Ambulatory Chronic Heart Failure Patients</brief_title>
  <official_title>Circulating Biomarkers as Prognostic Indicators of Death in Ambulatory Heart Failure Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Parma</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Parma</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Biomarkers representing distinct biological domains including neurohormonal, inflammatory,
      metabolic-nutritional, oxidative-nitrosative and myocardial injury, might alone or in
      combination provide prognostic information on mortality in heart failure patients with
      preserved or impaired systolic function.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Upon enrollment in the study, Troponin I (cTn I), BNP, norepinephrine, plasma renin activity,
      aldosterone, high-sensitivity C-reactive protein (hs-CRP), tumor necrosis factor-alpha
      (TNF-alpha), interleukin-6 (IL-6), soluble receptor of interleukin 2 (sIL-2R), leptin,
      prealbumin, free malondialdehyde, 15-F2t-isoprostane and protein-bound nitrotyrosine were
      measured in stable ambulatory, non diabetic, elderly heart failure patients. Patients were
      followed up until death or study termination (31st January 2009).
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>October 1998</start_date>
  <completion_date type="Actual">January 2009</completion_date>
  <primary_completion_date type="Actual">May 2003</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">124</enrollment>
  <condition>Heart Failure</condition>
  <arm_group>
    <arm_group_label>heart failure</arm_group_label>
  </arm_group>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      serum
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        heart failure patients with preserved or impaired systolic function
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  symptomatic congestive heart failure lasting at least six months

          -  reduced exercise tolerance

          -  impaired or preserved left ventricular ejection fraction

          -  cardiomegaly

        Exclusion Criteria:

          -  acute infection

          -  rheumatoid or other autoimmune diseases

          -  primary cachectic states (cancer, thyroid disease, severe liver disease)

          -  severe chronic lung disease

          -  neuromuscular disorders

          -  myocardial infarction within the previous 20 weeks

          -  diabetes mellitus

          -  chronic renal failure (serum creatinine level &gt; 2.0 mg/dl, &gt;177 micromol/L)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Aderville Cabassi, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Parma</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Universit√† di Parma</name>
      <address>
        <city>Parma</city>
        <zip>43126</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <verification_date>January 2009</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 29, 2010</study_first_submitted>
  <study_first_submitted_qc>April 29, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 30, 2010</study_first_posted>
  <last_update_submitted>May 3, 2010</last_update_submitted>
  <last_update_submitted_qc>May 3, 2010</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 4, 2010</last_update_posted>
  <responsible_party>
    <name_title>Aderville Cabassi</name_title>
    <organization>Hypertension and Cardiorenal Disease Center Dept Internal Medicine Nephrology and Health Sciences University of Parma</organization>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heart Failure</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

